GSK | GSK | ★★★★ | 6.23 | Q2 results | July 31, 2024 |
---|---|---|---|---|---|
Roche | ROG | ★★★★★ | 15.71 | Half year results | July 25, 2024 |
AstraZeneca | AZN | ★★★ | 16.47 | H1 and Q2 results | July 25, 2024 |
Nestle | NESN | ★★★★ | −0.26 | Half year results | July 25, 2024 |
Novartis | NOVN | ★★★ | 17.21 | Q2 results | July 18, 2024 |
Novo Nordisk | NOVO B | ★★ | 33.03 | Q2 results | August 7, 2024 |
L'Oreal | OR | ★★★ | −8.73 | Half year results | July 30, 2024 |
LVMH | MC | ★★★ | −4.70 | Half year results | July 23, 2024 |
ASML | ASML | ★★★ | 26.76 | Q2 results | July 17, 2024 |
SAP | SAP | ★ | 42.63 | H1 and Q2 results | July 22, 2024 |
Sanofi | SAN | ★★★★ | 7.56 | Q2 results | July 25, 2024 |